MREOMereo BioPharma Group plcvs its industry peers
A metric-by-metric comparison of Mereo BioPharma Group plc against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MREO본 종목 | $232M#6 | — | 8.1x#5 | 463.9x#4 | — | -3.2%#5 | -8021.4%#4 | 146.2%#1 | — | — | -83.2%#7 | — |
| MBIO | — | — | — | — | — | 87.8%#1 | — | -25.5%#3 | — | — | -70.1%#6 | — |
| MDCX | $11M#9 | — | — | — | — | -323.8%#9 | — | — | — | — | -92.9%#8 | — |
| MENS | $160M#7 | — | — | — | — | -54.7%#7 | — | — | — | — | -96.3%#9 | — |
| MRVI | $1.1B#4 | — | 5.2x#4 | 5.8x#1 | -28.3%#1 | 9.7%#4 | -115.9%#1 | -63.9%#6 | -76.4%#1 | — | 160.2%#2 | — |
| MSLE | $149M#8 | — | — | — | — | -20.5%#6 | — | — | — | — | — | — |
| NAMS | $2.6B#1 | — | 4.1x#3 | 116.4x#3 | -50.6%#2 | 16.1%#2 | -1002.9%#2 | -32.1%#4 | — | — | -10.6%#4 | — |
| NAMSW | $1.8B#2 | — | 2.9x#2 | 80.4x#2 | -50.6%#2 | 16.1%#2 | -1002.9%#2 | -32.1%#4 | — | — | 19.3%#3 | — |
| NBP | $434M#5 | — | 1.9x#1 | 686.5x#5 | — | -108.1%#8 | -14916.0%#5 | -20.0%#2 | -384.3%#2 | — | -55.7%#5 | — |
| NBTX | $1.7B#3 | — | — | — | — | — | — | — | — | — | 228.4%#1 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-09-18.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice